Gene: ERN1
Official Full Name: endoplasmic reticulum to nucleus signaling 1provided by HGNC
Gene Summary: This gene encodes the transmembrane protein kinase inositol-requiring enzyme 1. The encoded protein contains two functional catalytic domains, a serine/threonine-protein kinase domain and an endoribonuclease domain. This protein functions as a sensor of unfolded proteins in the endoplasmic reticulum (ER) and triggers an intracellular signaling pathway termed the unfolded protein response (UPR). The UPR is an ER stress response that is conserved from yeast to mammals and activates genes involved in degrading misfolded proteins, regulating protein synthesis and activating molecular chaperones. This protein specifically mediates the splicing and activation of the stress response transcription factor X-box binding protein 1. [provided by RefSeq, Aug 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00105 | ERN1 Knockout cell line (A549) | Human | ERN1 | 1:3~1:4 | Negative | Online Inquiry |
KO00190 | ERN1 Knockout cell line (HeLa) | Human | ERN1 | 1:3~1:6 | Negative | Online Inquiry |
KO00543 | ERN1 knockout cell line (HCT 116) | Human | ERN1 | 1:2~1:4 | Negative | Online Inquiry |
KO00544 | ERN1 Knockout cell line (HEK293) | Human | ERN1 | 1:3~1:6 | Negative | Online Inquiry |
ERN1 Gene Knockout Cell Lines are specifically engineered cellular models that feature a targeted deletion of the ERN1 gene, which encodes for the inositol-requiring enzyme 1 (IRE1). This gene plays a pivotal role in the unfolded protein response (UPR), a cellular stress response related to the endoplasmic reticulum's (ER) ability to manage protein folding and secretion. By knocking out the ERN1 gene, these cell lines facilitate the study of signaling pathways involved in ER stress and apoptosis, enabling researchers to delineate the complex networks that govern cellular responses to pathological conditions.
The primary function of ERN1 Gene Knockout Cell Lines lies in their ability to provide insights into the mechanisms through which ER stress impacts cellular health and disease progression. These cell lines can be utilized to assess changes in cell viability, apoptosis rates, and signaling mechanisms that are otherwise masked in wild-type cells due to compensatory pathways. Through detailed analyses of knockout cells, researchers can gain a clearer understanding of diseases such as cancer, neurodegeneration, and metabolic disorders that involve dysregulated ER stress responses.
The scientific importance of ERN1 Gene Knockout Cell Lines extends significantly into both research and clinical settings. Their application ranges from fundamental studies on cell biology to the development of novel therapeutic strategies aimed at modulating the UPR in various diseases. By understanding the role of ERN1 in different pathologies, researchers can identify potential drug targets and contribute to the advancement of personalized medicine.
What sets ERN1 Gene Knockout Cell Lines apart from alternative models, such as transient knockdowns or less specific gene editing approaches, is their stable and consistent gene deletion, allowing for long-term studies with reproducible results. Additionally, the precise genetic manipulation ensures that the cell lines retain the intended function alterations, improving experimental reliability.
These cell lines present valuable tools for researchers and clinicians alike, providing a robust platform for dissecting the intricacies of ER stress and its implications in health and disease. Their ease of use and potential for high-throughput screening make them indispensable in drug discovery and development processes.
At [Your Company Name], we pride ourselves on delivering high-quality biological products that empower the scientific community. With our expertise in gene editing technologies and commitment to advancing research, we offer reliable solutions like the ERN1 Gene Knockout Cell Lines to enhance your understanding of cellular mechanisms and foster innovation in therapeutic interventions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.